- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
High blood sugar linked to depression even in non Diabetics, finds Study
Netherlands: Higher levels of blood sugar or hyperglycemia are associated with depressive symptoms independent of lifestyle and cardiovascular risk factors, suggests a recent study in the journal Diabetologia. Further, the association between insulin resistance and depression was dependent on cardiovascular risk factors, specifically obesity.
People with type 2 diabetes are twice more likely to get depression compared to the general population. However, it is not clear whether insulin resistance and high blood sugar levels are directly involved in the etiology of depression. Therefore, Anouk F. J. Geraets, Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands, and colleagues investigated the association of hyperglycemia markers and insulin resistance, measured as continuous variables, with incident depressive symptoms over 4 years of follow-up.
The researchers used data from the longitudinal population-based Maastricht Study (n = 2848; mean age 59.9 ± 8.1 years, 48.8% women, 265 incident depression cases, 10,932 person-years of follow-up). Hyperglycaemia by fasting and 2 h post-load OGTT glucose levels, HbA1c, and skin autofluorescence (reflecting AGEs) were assessed at baseline. Matsuda insulin sensitivity index and HOMA-IR was used to calculate insulin resistance at baseline.
Depressive symptoms (nine-item Patient Health Questionnaire score ≥10) were assessed at baseline and annually over 4 years. The researchers used Cox regression analyses, and adjusted for demographic, cardiovascular and lifestyle risk factors.
Key findings of the study include:
- Fasting blood sugar, 2 h post-load glucose and HbA1c levels were associated with an increased risk for incident depressive symptoms after full adjustment (HR 1.20, HR 1.25, and HR 1.22 respectively)
- Skin autofluorescence, insulin sensitivity index and HOMA-IR were not associated with an increased risk for incident depressive symptoms after full adjustment (HR 0.99, HR 1.02, and HR 0.93 respectively).
"These findings establish temporal association between hyperglycemia and incident depressive symptoms, supporting the concept that hyperglycemia itself is involved in the etiology of depression, and thus may provide a potential target for the prevention of depression in individuals with and without type 2 diabetes," concluded the authors.
"The association of hyperglycaemia and insulin resistance with incident depressive symptoms over 4 years of follow-up: The Maastricht Study," is published in the journal Diabetologia.
DOI: https://link.springer.com/article/10.1007/s00125-020-05247-9
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751